We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection

By LabMedica International staff writers
Posted on 05 May 2025

Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. More...

Late-stage diagnoses often limit available treatment options and result in poorer patient outcomes. Efforts to identify biomarkers in a patient's blood have previously struggled due to the blood-brain barrier, which, while protecting the brain from infection, also prevents potential biomarkers from reaching the bloodstream. To address this issue, researchers have developed a new liquid biopsy method that could transform brain cancer detection by identifying DNA fragments from tumors and immune cells circulating in the blood, potentially allowing for earlier diagnosis. A description of the work has been published in Cancer Discovery.

The innovative liquid biopsy technique, developed by researchers at Johns Hopkins Kimmel Cancer Center (Baltimore, MD, USA), has already proven effective in detecting lung cancer and is currently used in clinical settings for lung cancer screening. This method utilizes machine learning, a form of artificial intelligence (AI), to detect patterns in circulating DNA fragments linked to brain tumors. Additionally, it identifies recurring patterns in the genome associated with brain cancer. In a study involving 505 patients from the United States and South Korea, this approach successfully detected brain cancer in approximately 75% of cases. The team later confirmed these results in a second group of around 95 patients from Poland. In contrast, previous liquid biopsy methods have detected brain cancer in fewer than 10% of cases.

A key factor contributing to the success of this approach is its ability to detect immune changes related to brain cancer. Patients with brain tumors exhibit immune suppression throughout their body and a distinct immune cell profile in their blood. These immune changes do not need to cross the blood-brain barrier to be identified. Following this, the team conducted a computer simulation to assess the potential of their liquid biopsy technique for screening the estimated 10 million individuals who visit emergency rooms or primary care clinics annually due to headaches. Typically, these patients are only referred for brain imaging if their physician suspects an underlying issue. However, in the simulation, patients whose liquid biopsy results suggested brain cancer were sent for imaging, which led to the detection of nearly 1,700 additional cancer cases compared to the conventional method. The next step for the team is to design a prospective trial to validate these findings in larger populations at higher risk for brain cancer.

“Our next-generation AI liquid biopsy approach combining DNA fragments and repeating genome patterns may accelerate brain cancer diagnosis,” said Victor E. Velculescu, M.D., Ph.D., co-director of cancer genetics and epigenetics at the cancer center. “It may ultimately allow patients to get care earlier, improving their treatment outcomes.”


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.